Search results
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 1 day agoPfizer Inc.’s recently made public that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports
Reuters via Yahoo Finance· 6 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters via AOL· 4 days agoThe company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 6 hours agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might...
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report - Pfizer...
Benzinga· 5 days agoIn a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc....
How the love story between von der Leyen and Pfizer turned sour
Euronews via Yahoo News· 4 days agoFrom making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and...
3 Blue-Chip Stocks to Buy on the Dip: May 2024
InvestorPlace· 5 hours agoWhile the latest Commerce Department report showed a notable deceleration in GDP growth, experts attribute much of this to robust spending on imported...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters via AOL· 4 days agoAstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via AOL· 4 days agoModerna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent...